✦ LIBER ✦

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis

✍ Scribed by Sara Khor,Jaclyn Beca,Murray Krahn,David Hodgson,Linda Lee,Michael Crump…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Analysis of Rituximab

✍ Jennie H. Best; John Hornberger; Stephen J. Proctor; Louis F. Omnes; Fred Jost 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Impact of rituximab on treatment outcome

✍ Linda Lee; Michael Crump; Sara Khor; Jeffrey S. Hoch; Jin Luo; Karen Bremner; Mu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Cost-effectiveness of rituximab (MabTher

✍ M. T. Groot; P. J. Lugtenburg; J. Hornberger; P. C. Huijgens; C. A. Uyl-de Groot 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Cost-Effectiveness Analysis of the Addit

✍ Felicetto Ferrara, Dr Roberto Ravasio 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

Comparative effectiveness and cost of ad

✍ Robert I. Griffiths; Michelle L. Gleeson; Joseph Mikhael; Martin H. Dreyling; Ma 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 686 KB

A systematic review and meta-analysis of

✍ Cheng Fang; Wei Xu; Jian-Yong Li 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 470 KB